Agenus Reports Three-Year Survival Data for BOT+BAL in Recurrent Ovarian Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, announced three-year follow-up results from the ovarian cancer cohort of its 400+ patie...

October 06, 2026 | Tuesday | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
Mironid Doses First Patients in Phase 1 Trial of LoAc® Therapy for ADPKD

Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of Mironid’s lead LoAc® small molecule in healthy volunteers Dosing ...

October 02, 2026 | Friday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Genentech’s Fenebrutinib Receives FDA Priority Review for Relapsing and Progressive Multiple Sclerosis

Fenebrutinib cut relapses by 51% and 58% vs teriflunomide in Phase III RMS trials (FENhance 1 & 2) while showing a consistent, positive trend in dela...

October 01, 2026 | Thursday | News
Vanda Reports Positive Phase III Results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in a...

October 01, 2026 | Thursday | News
Terumo Neuro to Acquire Arsenal Medical to Expand Liquid Embolic Portfolio

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing Ne...

October 01, 2026 | Thursday | News
Verdiva Bio Presents VRB-103 Oral Amylin Data for Obesity Treatment

Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing the development of a portfol...

September 30, 2026 | Wednesday | News
Innovent Reports Phase 1 Data for IBI3003 Trispecific Antibody in Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercializat...

September 30, 2026 | Wednesday | News
Caspian Therapeutics Reports KO-7246 Data in Type 1 and Type 2 Diabetes

– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models – – KO-7246...

September 30, 2026 | Wednesday | News
Accuray and Samsung NeuroLogica Advance Volumetric Imaging for CyberKnife Platform

Accuray Incorporated (NASDAQ: ARAY) announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogi...

September 29, 2026 | Tuesday | News
Elevar Therapeutics Receives FDA Approval for Lyrfigtu in FGFR2-Altered Bile Duct Cancer

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment...

September 25, 2026 | Friday | News
NanoImaging Services and Proteos Launch TrueCourse Biosciences to Integrate Drug Discovery Capabilities

NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have  announced the launch of TrueCourse Biosciences, an in...

September 24, 2026 | Thursday | News
Andelyn Biosciences Begins Commercial Manufacturing of FDA-Approved Fayuvi Gene Therapy

Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...

September 23, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close